Aref Al‐Kali
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 177
- Acute Myeloid Leukemia Research 154
- Chronic Myeloid Leukemia Treatments 66
- Genetics 103
- Myeloproliferative Neoplasms: Diagnosis and Treatment 70
- Chronic Lymphocytic Leukemia Research 30
- Co-authors
- Mark R. Litzow (125 shared papers)Ayalew Tefferi (95 shared papers)Animesh Pardanani (69 shared papers)Kebede H. Begna (83 shared papers)Naseema Gangat (111 shared papers)Mrinal M. Patnaik (129 shared papers)William J. Hogan (91 shared papers)Terra L. Lasho (30 shared papers)
- Journals
- Blood (80 papers)American Journal of Hematology (16 papers)Journal of Clinical Oncology (14 papers)Blood Cancer Journal (12 papers)British Journal of Haematology (8 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Aref Al‐Kali
193 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 86
- Hematology 1.5k
- Genetics 1.0k
- Molecular Biology 1.0k
- Rheumatology 203
- Cancer Research 183
Countries citing papers authored by Aref Al‐Kali
This map shows the geographic impact of Aref Al‐Kali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aref Al‐Kali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aref Al‐Kali more than expected).
Fields of papers citing papers by Aref Al‐Kali
This network shows the impact of papers produced by Aref Al‐Kali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aref Al‐Kali. The network helps show where Aref Al‐Kali may publish in the future.
Co-authors
The 25 scholars most cited alongside Aref Al‐Kali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 217 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 180 | |
| 2 | 2013 | 176 | |
| 3 | 2018 | 173 | |
| 4 | 2013 | 148 | |
| 5 | 2020 | 91 | |
| 6 | 2016 | 78 | |
| 7 | 2017 | 68 | |
| 8 | 2011 | 64 | |
| 9 | 2014 | 52 | |
| 10 | 2019 | 50 | |
| 11 | 2015 | 49 | |
| 12 | 2014 | 45 | |
| 13 | 2018 | 43 | |
| 14 | 2017 | 42 | |
| 15 | 2017 | 42 | |
| 16 | 2021 | 40 | |
| 17 | 2016 | 37 | |
| 18 | 2020 | 34 | |
| 19 | 2017 | 33 | |
| 20 | 2010 | 31 |
About Aref Al‐Kali
Aref Al‐Kali is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Oncology, having authored 217 papers that have together received 2.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (154 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (70 papers), Chronic Myeloid Leukemia Treatments (66 papers), Chronic Lymphocytic Leukemia Research (30 papers), Acute Lymphoblastic Leukemia research (27 papers), Hematological disorders and diagnostics (13 papers), Eosinophilic Disorders and Syndromes (11 papers) and Cancer Genomics and Diagnostics (11 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (1.0k citations), Molecular Biology (1.0k citations), Rheumatology (203 citations) and Cancer Research (183 citations). Aref Al‐Kali has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Mark R. Litzow, Ayalew Tefferi, Animesh Pardanani, Kebede H. Begna, Naseema Gangat, Mrinal M. Patnaik, William J. Hogan, Terra L. Lasho, Christy M. Finke and Curtis A. Hanson. Their work appears in journals such as Blood, American Journal of Hematology, Journal of Clinical Oncology, Blood Cancer Journal and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.